Tenax Therapeutics

NEWS

Business

BioSpace Movers & Shakers, Feb. 4

Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.

February 3, 2022

9 min read

Alex Keown

Business

New CEOs Named at Two Biopharma Companies

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

July 8, 2021

2 min read

Vanessa Doctor, RN

IN THE PRESS

Bio NC

Tenax Therapeutics to Host Virtual R&D Webinar with Scientific Experts Highlighting HELP Study Results

November 6, 2020

4 min read

Business

Tenax Therapeutics Gains North American Rights to Oral Levosimendan through Expanded License Agreement with Orion Corporation

October 15, 2020

5 min read

Bio NC

Tenax Therapeutics Announces Late-Breaking Clinical Trial Presentation of Phase 2 HELP Study at Heart Failure Society of America (HFSA) Virtual Annual Scientific Meeting

October 2, 2020

4 min read

Bio NC

Tenax Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference

September 1, 2020

3 min read

Drug Development

Tenax Announces Late-Breaking Results from the HELP Study Accepted for Presentation at the Heart Failure Society of America (HFSA) Annual Scientific Meeting

August 31, 2020

4 min read

Business

Tenax Therapeutics Reports Second Quarter 2020 Results and Provides Business Update

August 17, 2020

8 min read

Business

Tenax Therapeutics Expands Board of Directors with the Appointment of Two New Directors, Steven Boyd and Keith Maher, MD

July 20, 2020

5 min read

Bio NC

Tenax Therapeutics Announces $8.0 Million Registered Direct and PIPE Offerings Priced At-the-Market Under Nasdaq Rules

July 6, 2020

5 min read

Deals

Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - June 03, 2020

June 3, 2020

3 min read

Drug Development

Tenax Therapeutics Reports Positive Results from Phase 2 Trial of Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

June 2, 2020

7 min read

JOBS